Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies to Distribute Luminex's Magpix

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex announced after the close of the market Wednesday that Life Technologies will sell and distribute the firm's Magpix instrument worldwide.

Magpix, which was launched last year, is a compact multiplex analyzer that rapidly detects 50 different analytes simultaneously on a single sample, including proteins and nucleic acids. The system is based on Luminex's xMAP technology and provides nearly 5,000 data points in under an hour.

"Magpix represents a unique platform through which Life Technologies can make its cutting-edge antibody content accessible for a broad range of protein quantitation needs in basic and clinical research," Peter Dansky, president of molecular and cell biology at Life Technologies, said in a statement.

Financial and other terms of the agreement were not disclosed.

The Scan

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.